EconomyMarkets

Philips recalls some 3-4 million “CPAP”, ventilator machines due to foam part By Reuters

© Reuters. FILE PHOTO: Dutch technology company Philips’ logo is seen at company headquarters in Amsterdam, Netherlands, January 29, 2019. REUTERS/Eva Plevier

By Toby Sterling

AMSTERDAM (Reuters) – Philips, the Dutch medical equipment company, on Monday (NASDAQ:) said it would recall ventilators and “CPAP” breathing devices globally because of a foam part that might degrade and be inhaled.

The company said that though the matter would cause “revenue headwinds” in its sleep & respiratory care division, that would be compensated by strength in other businesses. It left its full year financial guidance of “low-to-mid-single-digit” comparable sales growth unchanged.

Philips had first disclosed the issue, for which it then took a 250 million euro ($303 million) charge, in its first quarter-earnings report in April.

The company’s guidance is for users of the CPAP machines, which help people with sleep apnea, to halt usage. Doctors with patients using life-sustaining ventilators should first consider whether the potential danger from the foam outweighs other risks.

The degrading foam, which is used to dampen the machines’ sound, can turn into small, inhaled particles, irritating airways and potentially causing cancer, Philips said. Gasses released by the degrading foam may also be toxic or carry cancer risks.

Philips spokesman Steve Klink said the company was working with health authorities on a safe replacement for the foam, but the new material must first clear testing and regulatory hurdles.

“Philips aims to address all affected devices” as soon as possible, the company said in a statement.

In April, Philips said first quarter core earnings surged 74% in the first quarter to 362 million euros ($438 million), compared with the same period a year earlier, on a 9% rise in comparable sales.

Shares closed at 46.38 euros on Friday, up 1.6% in the year to date.

($1 = 0.8263 euros)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.


Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button